Stephen L Sabba, Director, on June 16, 2026, sold 2,145 shares in Ligand Pharmaceuticals (LGND) for $544,830. Following the Form 4 filing with the SEC, Sabba has control over a total of 33,629 common shares of the company, with 33,629 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/886163/000110465926075456/xslF345X05/tm2618247-1_4seq1.xml